Insulin-like growth factor binding proteins in femoral and vertebral bone marrow stromal cells: Expression and regulation by thyroid hormone and dexamethasone
M. Milne et al., Insulin-like growth factor binding proteins in femoral and vertebral bone marrow stromal cells: Expression and regulation by thyroid hormone and dexamethasone, J CELL BIOC, 81(2), 2001, pp. 229-240
Insulin-like growth factor (IGF)-I is an important regulator of bone metabo
lism. Clinical observations suggest that different anatomic sites within th
e adult skeleton respond differently to hormonal and therapeutic treatment,
and recent studies on bone marrow stromal cells in culture show that there
are skeletal site-dependent differences in the gene expression of IGF-I. T
he actions of ICF-I and -II on bone cells are known to be modulated by the
IGF binding proteins (IGFBP)-1 through -6 and the Type I and Type II IGF re
ceptors. Therefore, we compared the expression of IGFBP-1 through -6 in adu
lt female rat bone marrow stromal cell cultures derived from two separate s
keletal sites: vertebrae and femurs. The cultures were maintained simultane
ously under conditions that support osteoblast differentiation from osteopr
ogenitors present in the femoral and vertebral marrow cell populations. We
also addressed whether ICFBP messenger RNA levels are regulated by thyroid
hormone (T-3) and dexamethasone (dex) treatment in femoral vs, vertebral ma
rrow stromal cells in vitro, since steroid hormones play an important role
in skeletal function. Northern blot analyses revealed that there are distin
ct skeletal site differences in the gene expression of IGFBPs. The vertebra
l marrow cultures express IGFBP-2 through -6 mRNAs, with IGFBP-2, IGFBP-4,
and IGFBP-6 mRNAs predominating. The femoral marrow stromal cell cultures e
xpress only IGFBP-4 and IGFBP-6. Importantly, vertebral marrow cultures hav
e much higher ICFBP mRNA steady-state levels than femoral cultures for all
the detected ICFBP transcripts. IGFBP-1 is not detected in either femoral o
r vertebral cultures. In addition to a skeletal site difference, we show th
at T-3 and dex regulate the expression of specific ICFBP mRNAs. T-3 treatme
nt also upregulates IGF-I protein secretion by vertebral marrow stromal cel
l cultures. Interestingly, the type I receptor for IGF-I was expressed equi
valently in cultures from the two skeletal sites. These findings have impor
tant implications for the anatomical site specificities of hormonal respons
es that are noted in the skeleton. (C) 2001 Wiley-Liss, Inc.